Humboldt
New York · Pre-Seed–Series A · 3 people tracked
Investment thesis
Exclusive synthetic biology investor focused on companies replacing industrial inputs with biology-based alternatives, led by a UCSF-trained PhD cell biologist offering deep research expertise and global Latin America–Europe reach.
Team · 3 people
from the firm's websiteBenjamin Quiroga, a business-trained co-founder based in Chile, partners with deeply technical co-GPs to give early-stage synthetic biology founders lab-savvy mentorship and commercial strategy while investing globally.
Latino investor with engineering, data analytics and business training who combines consulting and biotech co-founder experience with managing >$2B in multi-asset portfolios and structuring $500M+ in commercial real estate.
Sebastian Bernales, a Chilean former VP of Discovery Biology at Medivation who helped develop Xtandi before its $14B Pfizer acquisition, builds globally distributed biotech models and US–Latin America scientific ties.
What they invest in
from 8 of 18 portfolio companiesBiotech ×7AI & Machine Learning ×4Medical Devices ×3Deep Tech ×2AgTech ×1Climate Tech ×1FoodTech ×1Healthtech ×1
HQs:United States×3
Investments · 18 tracked
founders shown can be your intro pathAnsa Biotechnologies develops an enzyme-based process to manufacture DNA, offering an alternative to the established chemical synthesis methods used in the industry.
BiotechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inJason T. Gammack(Executive Officer, Director)Yanniv T. Dorone(Director)Daniel T. Lin-Arlow(Executive Officer, Director)Chenny T. Zhang(Director)
Cellineobio develops cell engineering and bioprocess technology platforms.
AI & Machine LearningBiotechDeep TechMedical Devices
Nabiha Saklayen, PhD(Co-Founder & CEO)inMarinna Madrid, PhD(Co-Founder & Chief Product Officer)
Finch is a microbiome therapeutics company that develops innovative microbiome assets designed from human microbiota transplantation studies, targeting a range of therapeutic areas.
BiotechMedical Devices
GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling.
AI & Machine LearningBiotechMedical DevicesCambridge, US
George Church(Co-Founder & Scientific Advisor)Parastoo Khoshakhlagh(Chief Executive Officer & Co-Founder)Alex Ng(Chief Innovation Officer & Co-Founder)
Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.
Climate TechFoodTechBerkeley, US
Ilan Eitan Fischer(Executive Officer, Director)David Bowman(Director)
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Frequently asked questions
- What stage does Humboldt invest at?
- Humboldt invests at the Pre-Seed, Seed, Series A stages.
- What is Humboldt's typical check size?
- Humboldt typically writes checks of $100K – $5M.
- What sectors does Humboldt focus on?
- Humboldt focuses on AgTech, AI & Machine Learning, Biotech, FoodTech, Healthtech, New Materials.
- Where is Humboldt located?
- Humboldt is headquartered in New York, US.
- Does Humboldt lead rounds?
- Humboldt typically participates in rounds rather than leading them.
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Snatched Ventures is a venture capital firm that partners with entrepreneurs pursuing bold, transformative visions, offering strategic support to help scale breakthrough innovations.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.


